The IVDR provides stricter oversight in many areas as compared to the EU’s previous In Vitro Device
Source: https://ec.europa.eu
The European Union’s (EU) Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), which were first published by the EU Parliament on May 5, 2017, establish new and crucial standards for medical device and in vitro diagnostic device manufacturers that market and sell their products in the EU. The new regulations provide a harmonized regulatory framework to ensure the safety and performance of devices.
Source: https://namsa.com
The IVDR defines IVDs as “software or systems” that are used in conjunction with the examination of specimens such as blood and tissue in order to obtain in-vitro information about “predisposition to a medical condition or a disease” or to “predict treatment response or reactions”, any of which could use algorithms.
Source: https://www.phgfoundation.org
In today’s ever-evolving regulatory environment, continuous monitoring of medical device performance through post-market surveillance is crucial in ensuring compliance with standards such as MDR and IVDR.
Read our blog to learn best practices for staying on top of these requirements and how a QMS can help.